论文部分内容阅读
目的:对比高通量血液透析与常规血液透析治疗慢性尿毒症的临床疗效。方法:本次研究对象为我院收治的64例慢性尿毒症患者,各为32例的研究组和对照组分别采用高通量血液透析与常规血液透析治疗,并对比两种透析方式的应用疗效。结果:研究组的治疗总有效率为90.63%优于对照组的65.63%,且差异P<0.05;其中血尿素氮和血肌酐与对照组相比差异较小,则P>0.05;而β-2微球蛋白和尿素清除指数的改善情况优于对照组,且P<0.05。结论:将高通量血液透析治疗慢性尿毒症患者可获得较高临床治疗效果,还能有效改善患者的肾功能指标,值得推广。
Objective: To compare the clinical effects of high-flux hemodialysis with conventional hemodialysis in the treatment of chronic uremia. Methods: The study was conducted in 64 cases of chronic uremia patients treated in our hospital, 32 cases in each study group and control group were treated with high-throughput hemodialysis and conventional hemodialysis, and compared the application of two types of dialysis efficacy . Results: The total effective rate of study group was 90.63%, which was higher than that of control group (65.63%) (P <0.05). The difference of blood urea nitrogen and serum creatinine was smaller than that of control group (P> 0.05) 2 microglobulin and urea clearance index better than the control group, and P <0.05. Conclusion: The high-throughput hemodialysis treatment of patients with chronic uremia can obtain a higher clinical effect, but also can effectively improve the patient’s renal function indicators, it is worth promoting.